Filing Flows › Regen BioPharma (RGBP) › R&D spending
Regen BioPharma (RGBP) R&D spending by quarter
Regen BioPharma's R&D spending was $2K in Q2 FY26 (second quarter fiscal 2026), -99% from Q1 FY26. Over the last 3 quarters it ranged from $2K (Q2 FY26) to $210K (Q1 FY26).
| Quarter | R&D spending | Q/Q | Y/Y |
|---|---|---|---|
| Q2 FY26 | $2K | -99% | — |
| Q1 FY26 | $210K | +526% | — |
| Q4 FY24 | $34K | — | — |
Q2 FY26 at a glance
Regen BioPharma, Q2 FY26: revenue $59K (0% year over year), operating margin -260.2%, net earnings $992K, operating cash flow −$63K. The chart follows the revenue to costs, profit and cash.
Questions
What is Regen BioPharma's R&D spending?
Regen BioPharma's R&D spending was $2K in Q2 FY26 (second quarter fiscal 2026), -99% from Q1 FY26.
How has Regen BioPharma's R&D spending changed?
Over the last 3 quarters it ranged from $2K (Q2 FY26) to $210K (Q1 FY26).